Brighton Jones’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$51K Sell
10,379
-15,706
-60% -$84.4K ﹤0.01% 1357
2026
Q2
$160K Buy
26,085
+13,590
+109% +$88.8K ﹤0.01% 1275
2026
Q1
$86.3K Buy
+12,495
New +$96.4K ﹤0.01% 1135

Other funds holding VNDA

Brighton Jones's VNDA Position: Q3 2026 in Review

Brighton Jones reduced its Vanda Pharmaceuticals (VNDA) stake by 60% in Q3 2026, selling an estimated $84.4K and leaving 10,379 shares worth $51K. The position accounts for ﹤0.01% of the portfolio, ranked #1357.

Brighton Jones first reported a position in VNDA in Q1 2026 and has held it in 3 quarters since. The position peaked at $160K in Q2 2026. 123 funds tracked by Wall St. Rank hold VNDA as of Q3 2026.

  • Brighton Jones held 10,379 shares of Vanda Pharmaceuticals worth $51K as of Q3 2026.
  • Brighton Jones sold 15,706 Vanda Pharmaceuticals shares in Q3 2026, an estimated $84.4K.
  • Vanda Pharmaceuticals made up ﹤0.01% of Brighton Jones's portfolio in Q3 2026, its #1357 holding.
  • Brighton Jones first reported a position in Vanda Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • Brighton Jones's Vanda Pharmaceuticals position peaked at $160K in Q2 2026.
  • 123 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2026.

Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.